The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Life sciences industry has regulatory compliance at the center of all its operations, so maintaining the integrity of data has always been a pressing need for this industry globally. Regulators such ...

The present world of digital transformation, streamlining workflows, enhancing operational efficiencies, and eliminating paper demands connected workflows with fully integrated systems and equipment.

Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...

With regulatory agencies like the FDA, EMA, and MHRA intensifying data integrity compliance, significant market opportunities exist in providing robust data management solutions. Organizations can ...

Microbial testing, analysis and environmental monitoring is fundamental to safe pharmaceutical manufacturing. Regulatory agencies require that the many components of the system implemented, from ...

Good manufacturing practices (GMP) are non-negotiable standards that guarantee the pharmaceutical industry produces only the highest-quality, safest, and most effective medicines. By strictly adhering ...

GMP is not merely a set of guidelines, but is the foundation on which public health and the integrity of the pharmaceutical industry stand ... The shift toward digital GMP means adapting to new tools ...

Glenmark Pharmaceuticals Ltd on Wednesday informed bourses that the United States Food and Drug Administration (USFDA) conducted a Good Manufacturing Practice (GMP) inspection at its manufacturing ...